CYP2B6 polymorphisms and nevirapine and efavirenz DILI

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2024年 / 2037卷 / 1期
关键词：
D O I：
10.1007/s40278-024-71697-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 4
相关论文
共 50 条
  • [21] Activity Variations of CYP2B6 Determine the Metabolic Stratification of Efavirenz
    Li, Xin-yue
    Liu, Qian
    Xu, Xiao-yu
    Wang, Jing
    Zhong, Yun-shan
    Jin, Le-hao
    Yuan, Jing
    Qian, Jian-chang
    Zhang, Xiao-dan
    CHEMICAL RESEARCH IN TOXICOLOGY, 2024, 37 (11) : 1867 - 1875
  • [22] Efavirenz and CYP2B6 polymorphism:: Implications for drug toxicity and resistance
    Nolan, D
    Phillips, E
    Mallal, S
    CLINICAL INFECTIOUS DISEASES, 2006, 42 (03) : 408 - 410
  • [23] Impact of CYP2B6 polymorphism on hepatic efavirenz metabolism in vitro
    Desta, Zeruesenay
    Saussele, Tanja
    Ward, Bryan
    Blievernicht, Julia
    Li, Lang
    Klein, Kathrin
    Flockhart, DavidA
    Zanger, Ulrich M.
    PHARMACOGENOMICS, 2007, 8 (06) : 547 - 558
  • [24] Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana
    Maseng, Monkgomotsi J.
    Tawe, Leabaneng
    Thami, Prisca K.
    Seatla, Kaelo K.
    Moyo, Sikhulile
    Martinelli, Axel
    Kasvosve, Ishmael
    Novitsky, Vladimir
    Essex, Max
    Russo, Gianluca
    Gaseitsiwe, Simani
    Paganotti, Giacomo M.
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2021, 14 : 335 - 347
  • [25] Association between CYP2B6 polymorphisms and Nevirapine-induced SJS']JS/TEN: a pharmacogenetics study
    Ciccacci, Cinzia
    Di Fusco, Davide
    Marazzi, Maria C.
    Zimba, Ines
    Erba, Fulvio
    Novelli, Giuseppe
    Palombi, Leonardo
    Borgiani, Paola
    Liotta, Giuseppe
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (11) : 1909 - 1916
  • [26] PXR Polymorphisms Interacted With CYP2B6 Polymorphisms on Methadone Metabolites
    Tsai, Hui-Ju
    Wang, Sheng-Chang
    Tian, Jia-Ni
    Chang, Tsung-Kai
    Ho, Ing-Kang
    Hsiao, Chin-Fu
    Chen, Chia-Hui
    Tan, Happy Kuy-Lok
    Lin, Linen
    Wu, Chi-Shin
    Su, Lien-Wen
    Huang, Chieh-Liang
    Yang, Yi-Hong
    Liu, Ming-Lun
    Lin, Keh-Ming
    Liu, Yu-Li
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (01) : 137 - 140
  • [27] Effects of clopidogrel and itraconazole on the disposition of efavirenz in relation to the CYP2B6 genetic polymorphisms in healthy subjects.
    Jiang, F.
    Shon, J.
    Yeo, C.
    Liu, K.
    Desta, Z.
    Flockhart, D.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S60 - S60
  • [28] Optimizing efavirenz treatment:: CYP2B6 genotyping or therapeutic drug monitoring?
    Rotger, Margalida
    Telenti, Amalio
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (04) : 335 - 336
  • [29] Detection of single nucleotide polymorphisms in CYP2B6 gene
    Zanger, UM
    Fischer, J
    Klein, K
    Lang, T
    CYTOCHROME P450, PT C, 2002, 357 : 45 - 53
  • [30] Efavirenz-associated CNS disorders linked to CYP2B6 variant
    Reactions Weekly, 2005, 1035 (1) : 5 - 5
12345